Advances in tetrahydropyrido[1,2- a ]isoindolone (valmerins) series: Potent glycogen synthase kinase 3 and cyclin dependent kinase 5 inhibitors-Reference-Cited by-同舟云学术

Advances in tetrahydropyrido[1,2- a ]isoindolone (valmerins) series: Potent glycogen synthase kinase 3 and cyclin dependent kinase 5 inhibitors

Published:2015-08 Issue: Volume:101 Page:274-287
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Boulahjar Rajâa,Ouach Aziz,Bourg Stéphane,Bonnet Pascal,Lozach Olivier,Meijer Laurent,Guguen-Guillouzo Christiane,Le Guevel Rémy,Lazar Saïd,Akssira Mohamed,Troin Yves,Guillaumet Gérald,Routier Sylvain

Funder

CNRS

Cancéropôle Grand Ouest

Association pour la Recherche contre le Cancer

Hubert Curien

Ligue Nationale contre le Cancer (Comité Grand-Ouest)

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference36 articles.

1. Recent developments of protein kinase inhibitors as potential AD therapeutics;Tell;Front. Cell. Neurosci.,2013

2. Cortical deficiency of laminin gamma1 impairs the AKT/GSK-3beta signaling pathway and leads to defects in neurite outgrowth and neuronal migration;Chen;Dev. Biol.,2009

3. The role of the Cdk5-p35 kinase in neuronal development

4. Mechanism of CDK5/p25 binding by CDK inhibitors;Mapelli;J. Med. Chem.,2005

5. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics;Jope;Neurochem. Res.,2007

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, antineoplastic activity of new pyrazolo[3,4-d]pyrimidine derivatives as dual CDK2/GSK3β kinase inhibitors; molecular docking study, and ADME prediction;Bioorganic Chemistry;2024-09

2. Exploration of Potential Cyclin-dependent Kinases and their Inhibitors to Combat Abnormal Signalling and Cancer;Current Signal Transduction Therapy;2024-07

3. Impact of GSK-3β and CK-1δ on Wnt signaling pathway in alzheimer disease: A dual target approach;Bioorganic Chemistry;2024-06

4. Innovative pathological network‐based multitarget approaches for Alzheimer's disease treatment;Medicinal Research Reviews;2024-04-28

5. Navigating the GSK-3β inhibitors as versatile multi-target drug ligands in Alzheimer’s disease intervention – A comprehensive review;Results in Chemistry;2024-01